Chloride Persulfate Wound Composition for Pain Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for periodontitis and wound healing, particularly in chronic or non-healing wounds, lack effective pain relief and sustainable, localized solutions that can be easily applied by patients, and often fail to prevent infection and promote optimal healing.
Innovation Solution
A topical composition containing a salt-shaped chloride compound, such as alkali or alkaline metal salts, combined with a persulfate oxidizing agent, which forms chloroxide or hypochlorite upon contact with moisture, providing antimicrobial and anti-inflammatory effects, and is suitable for use in creams, gels, or pastes for application on skin and mucous membranes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional wound healing treatments are used, then basic wound care is provided, but pain relief and sustainable localized treatment are insufficient
Solution Approach 1:
The patent transforms the chemical state of chloride compounds from stable salts to reactive forms through controlled reaction with persulfate oxidizing agents. This parameter change enables the composition to remain stable during storage yet become highly effective upon application, resolving the contradiction between reliability and ease of operation by allowing simple patient application with sustained therapeutic effect
Solution Approach 2:
The patent incorporates pain relief agents and antimicrobial components in advance within the adhesive composition. This preliminary action ensures that when patients apply the composition themselves, they immediately receive comprehensive treatment including pain relief, infection prevention, and wound healing promotion, eliminating the need for multiple separate treatments
2Object-affected harmful factors
If strong oxidizing agents are used to prevent infection, then antimicrobial effect is improved, but stability during storage deteriorates
Solution Approach 1:
The patent divides the antimicrobial system into separate stable components: chloride salts and persulfate oxidizing agents are stored separately or in stable combination, then activated upon application. This segmentation maintains storage stability while ensuring strong antimicrobial effect when needed, as the reactive species are generated only at the point of use
Solution Approach 2:
The patent uses chloride salts as stable intermediaries that can be stored safely, then converted to reactive chlorine species through reaction with persulfate. This intermediary approach allows the system to maintain long-term stability while still delivering potent infection prevention when activated
3Duration of action of stationary object
If localized treatment is applied to achieve sustainable results, then treatment effectiveness is improved, but application complexity increases
Solution Approach 1:
The patent designs the composition to be self-adhering and self-sustaining. The adhesive base allows patients to apply the treatment themselves without complex procedures, while the controlled release mechanism provides sustained local action. This self-service approach achieves both simplicity of application and long-lasting effectiveness
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition accelerates wound healing, reduces pain, and prevents infection, particularly in difficult-to-heal wounds, including those on the skin and gums, while being safe for use after dental treatments and suitable for long-term application.
Implementation Method 1
at least one oxidizing agent selected from the group of persulfate compounds
Implementation Method 2
a salt-form chloride compound selected from the group of alkali or alkaline earth metal salts and at least one oxidizing agent selected from the group of persulfate compounds
Data Source
Figure 1
Figure 2~3
Figure 4~5
AI summary
The invention relates to an agent, in particular a cosmetic and/or pharmaceutical agent, containing an active composition and optionally an adhesion composition, said active composition containing at least one organic or inorganic chlorine compound and at least one oxidation agent, for use in the treatment of wounds and/or hemorrhaging of the skin, mucous membranes or the gums, in particular in the absence of canker sores.